Aug 14, 2024 / 08:30PM GMT
Operator
Welcome to the Matinas BioPharma second-quarter 2024 financial results conference call. (Operator instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead.
Jody Cain - LHA Investor Relations - Investor Relations
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from Matinas BioPharma are Jerome Jabbour, Chief Executive Officer, and Keith Kucinski, Chief Financial Officer; Dr. Theresa Matkovits, Chief Development Officer, and Dr. Terry Ferguson, Chief Medical Officer, will be available during the question and answer session.
I'd like to remind listeners that remarks made during this call may state management's future intentions hopes, beliefs, expectations or projections. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements made pursuant to the safe harbor provisions of federal securities laws.
These forward-looking statements are based on current expectations and actual results
Q2 2024 Matinas BioPharma Holdings Inc Earnings Call Transcript
Aug 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers